CLINICAL TRIALS AND OBSERVATIONS Partial immune reconstitution of X-linked hyper IgM syndrome with recombinant CD40 ligand
نویسندگان
چکیده
1Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD; 2Department of Critical Care Medicine, NIH Clinical Center, Bethesda, MD; 3Metabolism Branch, National Cancer Institute (NCI), Bethesda, MD; 4Laboratory of Immunoregulation, NIAID, NIH, Bethesda, MD; 5Laboratory of Pathology, NCI, Bethesda, MD; 6Amgen, Seattle, WA; 7Arizona Allergy Associates, Phoenix, AZ; 8Clinical Services Program, SAIC-Frederick Inc, NCI-Frederick, NIH, Bethesda, MD; 9Department of Laboratory Medicine, NIH Clinical Center, Bethesda, MD; 10Office of the Clinical Director, NIAID, NIH, Bethesda, MD; 11Department of Pediatrics, University of Utah, Salt Lake City, UT; and 12Department of Pediatrics, University of Washington, Seattle, WA
منابع مشابه
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Effect of a single injection of humanized anti-CD154 monoclonal antibody on the platelet-specific autoimmune response in patients with immune thrombocytopenic purpura
Blockade of the CD40/CD154 signal is a potential immunomodulatory strategy for T-cell–mediated diseases. As a part of a phase 1, multicenter, dose-escalating trial of humanized monoclonal antibody to CD154 (IDEC-131/E6040) in patients with refractory immune thrombocytopenic purpura (ITP), the autoimmune response to glycoprotein IIb/IIIa (GPIIb/IIIa) was evaluated at successive time points. Five...
متن کاملCLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome
X-linked lymphoproliferative (XLP) disease is a primary immunodeficiency caused by a defect in the SH2D1A gene. At least 3 major manifestations characterize its clinical presentation: fatal infectious mononucleosis (FIM), lymphomas, and immunoglobulin deficiencies. Common variable immunodeficiency (CVID) is a syndrome characterized by immunoglobulin deficiency leading to susceptibility to infec...
متن کاملCLINICAL TRIALS AND OBSERVATIONS Upfront immunization with autologous recombinant idiotype Fab fragment without prior cytoreduction in indolent B-cell lymphoma
Idiotype vaccination for follicular lymphoma is primarily being developed as remission consolidation after chemotherapy. We investigated idiotype vaccination as primary intervention for treatmentnaive indolent B-cell lymphoma and in a separate cohort as remission consolidation after chemotherapy to assess immunization-induced immune responses in relation to progression-free survival (German Cli...
متن کاملSpotlight on anti-CD25: daclizumab in MS.
Monoclonal antibodies are a promising new class of therapeutic agents that can be employed to target specific molecules of the immune system or any tissue. They are currently being tested in a number of clinical trials in autoimmune diseases such as multiple sclerosis (MS). One of these, the humanized monoclonal anti-CD25 antibody daclizumab (Zenapax), is directed against the interleukin-2 (IL-...
متن کاملTherapeutic inhibition of the complement system. Y2K update.
Activation of complement is an essential part of the mechanism of pathogenesis of a large number of human diseases; its inhibition by pharmacological means is likely to suppress disease processes in complement mediated diseases. From this point of view low molecular weight synthetic inhibitors of complement are being developed and high molecular weight natural inhibitors of human origin present...
متن کامل